PharmaSGP Holding SE reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 65.34 million compared to EUR 63.25 million a year ago. Net income was EUR 10.69 million compared to EUR 10.64 million a year ago. Basic earnings per share from continuing operations was EUR 0.89 compared to EUR 0.89 a year ago.